Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity
Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome.
After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt
Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics.
Our sandpit workshops bring together researchers from different disciplines to develop research ideas for the early detection of cancer.